Ligand Reports Second Quarter 2020 Financial Results
Go back to Ligand Reports Second Quarter 2020 Financial Results| LIGAND PHARMA (NASDAQ: LGND) | Delayed: 288.89 -4.38 (1.49%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $293.27 | 52 Week High | $139.79 | |||
| Open | $294.99 | 52 Week Low | $82.07 | |||
| Day High | $294.99 | P/E | 671.84 | |||
| Day Low | $286.51 | EPS | $0.43 | |||
| Volume | 24,068 | |||||

